Autolus Therapeutics plc ( AUTL) - Key Metrics
AUTL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | $0.08 | -$0.30 | -$0.26 | -$0.20 |
| 2025Q2 | $0.08 | -$0.18 | -$0.27 | -$0.30 |
| 2025Q1 | $0.03 | -$0.26 | -$0.28 | -$0.31 |
AUTL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | -1.37 |
| 2025Q2 | ? | -3.17 |
| 2025Q1 | ? | -1.47 |
AUTL
Price: $1.56
52 week price:
Earnings Per Share: -1.09 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United Kingdom
Volume: 412700
Market Capitalization: 407.2 million